Charles Schwab’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-2,042,988
Closed -$6.44M 3455
2020
Q3
$6.44M Sell
2,042,988
-279,855
-12% -$894K ﹤0.01% 1947
2020
Q2
$6.76M Sell
2,322,843
-604,578
-21% -$1.91M ﹤0.01% 1884
2020
Q1
$8.26M Sell
2,927,421
-546,524
-16% -$1.76M ﹤0.01% 1566
2019
Q4
$11.3M Sell
3,473,945
-198,177
-5% -$575K 0.01% 1610
2019
Q3
$7.93M Sell
3,672,122
-2,019
-0.1% -$5.4K ﹤0.01% 1735
2019
Q2
$11.5M Buy
3,674,141
+204,999
+6% +$665K 0.01% 1503
2019
Q1
$12.9M Sell
3,469,142
-335,327
-9% -$1.13M 0.01% 1424
2018
Q4
$11M Sell
3,804,469
-37,404
-1% -$103K 0.01% 1392
2018
Q3
$10.1M Buy
3,841,873
+266,275
+7% +$654K 0.01% 1631
2018
Q2
$8.37M Buy
3,575,598
+142,413
+4% +$398K 0.01% 1712
2018
Q1
$10.1M Buy
3,433,185
+301,466
+10% +$823K 0.01% 1487
2017
Q4
$8.58M Sell
3,131,719
-38,040
-1% -$117K 0.01% 1588
2017
Q3
$10.7M Buy
3,169,759
+292,654
+10% +$814K 0.01% 1378
2017
Q2
$7.11M Buy
2,877,105
+584,481
+25% +$1.34M 0.01% 1588
2017
Q1
$5.21M Buy
2,292,624
+263,273
+13% +$582K 0.01% 1740
2016
Q4
$4.3M Buy
2,029,351
+353,471
+21% +$986K ﹤0.01% 1827
2016
Q3
$5.62M Buy
1,675,880
+17,106
+1% +$54.3K 0.01% 1573
2016
Q2
$5.21M Sell
1,658,774
-69,382
-4% -$231K 0.01% 1532
2016
Q1
$5.75M Sell
1,728,156
-86,170
-5% -$269K 0.01% 1427
2015
Q4
$6.42M Buy
1,814,326
+121,789
+7% +$510K 0.01% 1340
2015
Q3
$8.51M Buy
1,692,537
+79,581
+5% +$456K 0.01% 1101
2015
Q2
$10.4M Sell
1,612,956
-3,223
-0.2% -$21.6K 0.01% 1003
2015
Q1
$11.4M Buy
1,616,179
+328,534
+26% +$2.38M 0.02% 909
2014
Q4
$9.93M Buy
1,287,645
+184,460
+17% +$1.46M 0.01% 899
2014
Q3
$8.24M Sell
1,103,185
-263,676
-19% -$2.45M 0.01% 971
2014
Q2
$13.2M Buy
1,366,861
+51,118
+4% +$456K 0.02% 645
2014
Q1
$10.9M Buy
1,315,743
+34,495
+3% +$296K 0.02% 738
2013
Q4
$10.8M Buy
1,281,248
+529,485
+70% +$4.46M 0.02% 668
2013
Q3
$6.08M Buy
751,763
+130,147
+21% +$1.05M 0.01% 1010
2013
Q2
$4.85M Buy
+621,616
New +$4.85M 0.01% 1084

Other funds holding PDLI